FDA 和 EMA 在 RSV 孕妇疫苗接种问题上存在分歧：全球死亡率的可能后果。

The Pediatric Infectious Disease Journal Pub Date : 2023-10-11 DOI:10.1097/inf.0000000000004173

Joukje E Willemsen, José A M Borghans, Louis J Bont, Julia Drylewicz

{"title":"FDA 和 EMA 在 RSV 孕妇疫苗接种问题上存在分歧：全球死亡率的可能后果。","authors":"Joukje E Willemsen, José A M Borghans, Louis J Bont, Julia Drylewicz","doi":"10.1097/inf.0000000000004173","DOIUrl":null,"url":null,"abstract":"The European Medicines Agency and the US Food and Drug Administration have recently approved a maternal vaccine for respiratory syncytial virus. The US Food and Drug Administration limits vaccination to later in pregnancy. Mathematical modeling demonstrates that this vaccination window may reduce the global mortality impact of the vaccine by 12%. Policymakers should carefully consider vaccine risks and benefits to safeguard vulnerable infants effectively.","PeriodicalId":501652,"journal":{"name":"The Pediatric Infectious Disease Journal","volume":"151 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2023-10-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Disagreement FDA and EMA on RSV Maternal Vaccination: Possible Consequence for Global Mortality.\",\"authors\":\"Joukje E Willemsen, José A M Borghans, Louis J Bont, Julia Drylewicz\",\"doi\":\"10.1097/inf.0000000000004173\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"The European Medicines Agency and the US Food and Drug Administration have recently approved a maternal vaccine for respiratory syncytial virus. The US Food and Drug Administration limits vaccination to later in pregnancy. Mathematical modeling demonstrates that this vaccination window may reduce the global mortality impact of the vaccine by 12%. Policymakers should carefully consider vaccine risks and benefits to safeguard vulnerable infants effectively.\",\"PeriodicalId\":501652,\"journal\":{\"name\":\"The Pediatric Infectious Disease Journal\",\"volume\":\"151 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-10-11\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"The Pediatric Infectious Disease Journal\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1097/inf.0000000000004173\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"The Pediatric Infectious Disease Journal","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1097/inf.0000000000004173","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}

引用次数: 0

摘要

欧洲药品管理局和美国食品和药物管理局最近批准了一种呼吸道合胞病毒母体疫苗。美国食品和药物管理局将疫苗接种时间限制在怀孕后期。数学模型显示，这一疫苗接种窗口可将疫苗对全球死亡率的影响降低 12%。政策制定者应仔细考虑疫苗的风险和益处，以有效保护易感婴儿。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

Disagreement FDA and EMA on RSV Maternal Vaccination: Possible Consequence for Global Mortality.

The European Medicines Agency and the US Food and Drug Administration have recently approved a maternal vaccine for respiratory syncytial virus. The US Food and Drug Administration limits vaccination to later in pregnancy. Mathematical modeling demonstrates that this vaccination window may reduce the global mortality impact of the vaccine by 12%. Policymakers should carefully consider vaccine risks and benefits to safeguard vulnerable infants effectively.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

The Pediatric Infectious Disease Journal

自引率

0.00%

发文量